Publications by authors named "Yoshiko Inada"

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder presenting with progressive heterotopic ossification (HO) in soft tissues. Early-stage FOP is characterized by recurrent episodes of painful tissue swelling (flare-ups), with numerous proliferation-activated mesenchymal stromal cells (MSCs) subsequently causing HO. However, the mechanisms underlying flare-up progression remain unclear.

View Article and Find Full Text PDF

Background: Ullrich congenital muscular dystrophy (UCMD) is caused by a deficiency in type 6 collagen (COL6) due to mutations in COL6A1, COL6A2, or COL6A3. COL6 deficiency alters the extracellular matrix structure and biomechanical properties, leading to mitochondrial defects and impaired muscle regeneration. Therefore, mesenchymal stromal cells (MSCs) that secrete COL6 have attracted attention as potential therapeutic targets.

View Article and Find Full Text PDF

Background: Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease caused by a gain-of-function mutation in ACVR1, which is a bone morphogenetic protein (BMP) type I receptor. Moreover, it causes progressive heterotopic ossification (HO) in connective tissues. Using FOP patient-derived induced pluripotent stem cells (FOP-iPSCs) and mouse models, we elucidated the underlying mechanisms of FOP pathogenesis and identified a candidate drug for FOP.

View Article and Find Full Text PDF

Cox17p is essential for the assembly of functional cytochrome c oxidase (CCO) and for delivery of copper ions to the mitochondrion for insertion into the enzyme in yeast. Although this small protein has already been cloned or purified from humans, mice, and pigs, the function of Cox17p in the mammalian system has not yet been elucidated. In vitro biochemical data for mammalian Cox17p indicate that the copper binds to the sequence -KPCCAC-.

View Article and Find Full Text PDF

Cox17p, essential for the assembly of functional cytochrome c oxidase (CCO) in Saccharomyces cerevisiae, has been believed to deliver copper ions to the mitochondrion for insertion into the enzyme. We have recently isolated an approximately 20 kb genomic fragment of the mouse COX17. Reporter assay experiments have shown that most of the promoter activity was restricted to a 0.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Yoshiko Inada"

  • - Yoshiko Inada's recent research focuses on the mechanisms and therapeutic targets related to muscle regenerative disorders, particularly in conditions like Ullrich congenital muscular dystrophy and fibrodysplasia ossificans progressiva, using induced pluripotent stem cells (iPSCs) and mouse models to explore potential interventions.
  • - Inada's findings indicate that induced pluripotent stem cell-derived mesenchymal stromal cells (iMSCs) possess distinct regenerative capabilities and highlight their potential in delivering therapeutic agents, such as ACVR2B-Fc fusion protein, to combat abnormal ossification processes associated with rare genetic diseases.
  • - The research also investigates the cellular and molecular dynamics involved in disorders characterized by abnormal muscle and bone development, including the role of neural crest-derived progenitor cells, helping to deepen the understanding of tissue regeneration mechanisms and potential treatments.